USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 191 filers reported holding USANA HEALTH SCIENCES INC in Q1 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $224,000 | -26.3% | 4,000 | 0.0% | 0.02% | -9.5% |
| Q2 2022 | $304,000 | -4.4% | 4,000 | 0.0% | 0.02% | +5.0% |
| Q1 2022 | $318,000 | -37.2% | 4,000 | -20.0% | 0.02% | -35.5% |
| Q4 2021 | $506,000 | +9.8% | 5,000 | 0.0% | 0.03% | +19.2% |
| Q3 2021 | $461,000 | -10.0% | 5,000 | 0.0% | 0.03% | -10.3% |
| Q2 2021 | $512,000 | +4.9% | 5,000 | 0.0% | 0.03% | -3.3% |
| Q1 2021 | $488,000 | +26.8% | 5,000 | 0.0% | 0.03% | +3.4% |
| Q4 2020 | $385,000 | -92.4% | 5,000 | -99.0% | 0.03% | -89.6% |
| Q3 2020 | $5,088,000 | +1286.4% | 505,000 | +10000.0% | 0.28% | +600.0% |
| Q2 2020 | $367,000 | +27.0% | 5,000 | 0.0% | 0.04% | +5.3% |
| Q1 2020 | $289,000 | +23.0% | 5,000 | +150.0% | 0.04% | +22.6% |
| Q4 2018 | $235,000 | -2.5% | 2,000 | 0.0% | 0.03% | +19.2% |
| Q3 2018 | $241,000 | +4.3% | 2,000 | 0.0% | 0.03% | -3.7% |
| Q2 2018 | $231,000 | – | 2,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 25,432 | $2,345,000 | 2.04% |
| DENALI ADVISORS LLC | 21,013 | $1,937,000 | 0.81% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 22,000 | $2,028,000 | 0.56% |
| CLARK ESTATES INC/NY | 41,500 | $3,826,000 | 0.55% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 24,800 | $2,287,000 | 0.50% |
| HEARTLAND ADVISORS INC | 60,000 | $5,532,000 | 0.33% |
| Zebra Capital Management LLC | 2,578 | $238,000 | 0.29% |
| ACADIAN ASSET MANAGEMENT LLC | 672,674 | $61,988,000 | 0.24% |
| Renaissance Technologies | 1,518,700 | $140,024,000 | 0.18% |
| Cypress Capital, LLC | 14,121 | $1,302,000 | 0.16% |